在Mtb/HIV联合感染期间,肺瘤的免疫反应:对病原和治疗的影响
Deepak Kaushal1, Dhiraj K Singh1, Smriti Mehra1
1Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Pathogens (Basel, Switzerland)
|September 28, 2023
概括
结核病 (TB) 仍然是艾滋病毒感染者的首要死亡原因,即使使用了抗逆转录病毒疗法 (ART). 了解HIV诱导的结核病再激活的分子机制对于开发更好的治疗方法和疫苗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 结核病 (TB) 和艾滋病毒是全球领先的健康威胁,结核病导致艾滋病毒感染者的四分之一死亡.
- 同时感染艾滋病毒显著增加了潜伏结核病感染发展为活跃结核病的风险.
研究的目的:
- 调查为什么艾滋病毒同时感染导致对结核病复激活的高度敏感性,尽管抗逆转录病毒疗法 (ART) 有效控制病毒.
- 了解HIV诱导的结核病活性化背后的分子机制.
- 为共同感染的个人确定改善治疗方法和疫苗的策略.
主要方法:
- 这项研究回顾了当前对控制HIV联合感染中的结核病再激活的分子机制的理解.
- 它讨论了结合抗结核病和抗逆转录病毒方法的潜在治疗策略.
主要成果:
- 抗逆转录病毒疗法 (ART) 可以降低结核病发病率,但不能完全恢复共感染个体对Mycobacterium tuberculosis (Mtb) 的免疫控制.
- 即使在有效的病毒抑制下,艾滋病毒共感染个体中仍然存在对潜在结核病感染 (LTBI) 再激活的显著易感性.
结论:
- 对HIV诱导的结核病再激活的分子机制的进一步研究是必不可少的.
- 开发新的治疗方法和疫苗对于减轻慢性免疫激活和改善Mtb/HIV联合感染患者的治疗结果至关重要.
相关概念视频
Pulmonary Tuberculosis II
256
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
256
Pulmonary Tuberculosis I
257
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
257
Pulmonary Tuberculosis IV
157
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
157
Pulmonary Tuberculosis V
194
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
194
Pulmonary Tuberculosis III
357
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
357
Cell-mediated Immune Responses
68.7K
Overview
68.7K


